Case Study: Royalty Pharma Streamlines Research Workflows with AlphaSense

Royalty Pharma Uses Expert Insights in AlphaSense as Tool for Due Diligence

Royalty Pharma, the world's largest investor in biopharmaceutical royalties, faced significant challenges in managing its research and due diligence processes. With a lean team of analysts, the company struggled with fragmented data across numerous sources, slow and error-prone workflows, and the inability to effectively share valuable internal intelligence. To overcome these obstacles, Royalty Pharma turned to the AlphaSense platform for a solution.

By implementing AlphaSense's generative AI-powered search, Enterprise Intelligence, and other tools, the company created a unified, searchable knowledge base. This solution dramatically streamlined their research, reducing the time spent on daily workflows by 30%. The platform's efficiency is so powerful that a team of just three to four AlphaSense-empowered analysts can now perform the work that would typically require over 100 people, enabling faster and more confident investment decisions.

Royalty Pharma

Sandy Balkin

SVP of Strategy and Analyticshttps://media.licdn.com/dms/image/C4D03AQE0oS52HbP00g/profile-displayphoto-shrink_400_400/0/1650921708041?e=1710374400&v=beta&t=Y35RB2d6XtLkR5ItklYfJx5xgqibmVUbVbTGoSOK6YY